Brought to you by 
Phase-I hooks up with Amersham, Molecular Dynamics
13 Jul 1999
Executive Summary
Phase-I (toxicology testing) will join Molecular Dynamics and Amersham Pharmacia Biotech's Microarray Technology Access program, which they started in 1996 to give corporations and institutions early access to their microarray technology.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Phase-I hooks up with Amersham, Molecular Dynamics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice